Navigation Links
Patients Undergoing Breast Radiation Are Facing Complications

Patients who receive accelerated-partial breast radiation therapy, after undergoing lumpectomy for breast cancer, using a balloon brachytherapy system, are at the risk// of developing seroma, where the fluid will be retained in their breast, which may require aspiration else resulting in physical exam more difficult.

The researchers studied 38 patients who had a balloon brachytherapy catheter inserted during lumpectomy surgery to remove the cancerous tumor from their breast at Tufts-New England Medical Center in Boston and Rhode Island Hospital in Providence, R.I. With a balloon brachytherapy system, after removing the cancerous lump from the breast, doctors implant a small balloon into the space where the tumor was removed. Radiation oncologists then insert a radiation source inside the breast temporarily to deliver high doses of radiation to the tumor site to eliminate any cancer cells that may remain after surgery. This method of partial breast irradiation is currently being studied to see if it is as effective as external beam radiation after lumpectomy at keeping breast cancer from returning.

The women in the study were followed for an average of 17 months. Of the 38 patients, 76.3 percent of them developed seroma in their breast and 68.4 percent of the patients had it persist beyond six months. In addition, 11 percent of the patients required additional biopsy or surgery to rule out recurrence, due to suspicious asymmetries within the seroma cavity’s lining.

According to the study, seroma development was quite high in patients treated with a balloon brachytherapy system, when the device is placed at the time of lumpectomy surgery. Persistent seroma formation was linked to patients who had higher body weights, and was less likely in those that had a post-operative infection. It is uncertain if delaying catheter insertion to sometime other than the lumpectomy surgery will result in lower rates of seroma formation.

'S
'"/>




Page: 1 2

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patients often assume wrongly that they are allergic to penicillin
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. Hemochromatosis Patients Blood is Safe
9. Patients Pressure Would Result In Overprescription
10. Risk Of Decongestants In Hypertensive Patients
11. Interference helps Heart Patients

Post Your Comments:
(Date:11/30/2009)...s in animals , , MONDAY, Nov. 30 (Heal...that stem cells from transplanted human-derived um...heart disorders. , Scientists already know tha...st of different kinds of cells in the laboratory, ... Seoul, Korea, co-author of one of the studies, sa...
(Date:11/30/2009)...wire/ -- Kemin Foods, L.C. ("Kemin") and OmniActiv...Technologies, Ltd. ("OmniActive") have reached an ...agree that Kemin,s US Patent No. 5,382,714 ("the ,...cation and Recrystallization of Lutein from Saponi...reissues of that patent are valid and enforceable....
(Date:11/30/2009)...PRNewswire/ -- During this time of year, people be...oved one with Alzheimer,s disease or other form of...truggle with appropriate gift items. ,, Brookd...f senior living residences in the nation, includin...ggestions. ,, A listening device with recordin...
(Date:11/30/2009)... and Europa Uomo, the European,advocacy movement ...d into an,affiliated partnership as part of their...ient awareness in Europe with regards to urologica...ecretary-General of the EAU: "Thanks to this uniqu...in access to the latest information on,optimum su...
(Date:11/30/2009)...ched a series of clinical trials in order to asses... approach involves the application of personalised...rom the patient him or herself and designed to com...frequent malignant tumours. The new therapy is adm...the standard, first-line treatment involving surgi...
Breaking Medicine News(10 mins):Health News:Gift Ideas for Loved Ones with Alzheimer's/Dementia 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6
...y hospital's inability to activate emergency power...ddle of a cataract surgery was awarded over Rs one... "It had taken about 15-20 minutes of crucial ...," observed the Consumer Disputes Redressal Forum ...
..., spread of infectious disease and food security u...ry in order to acquire the proper balance between ...phy professor of Kansas State University has used ...in uses remote sensing, in combination with other ...
...Toronto General Hospital, researchers have discove...ion //of specific repair cells from the bone marro...le it has long been known that bone marrow cells h... stem cells in repairing a damaged heart, restorin...
...a good 14 years has revealed that regular exercise...e body weight has an impact in cutting down the ri...uthor of the study, said "Even though erectile pro...." Obesity also affects sexual health, he said. ...
...f BARACLUDE? (entecavir) for the treatment of chro...proval by the Drug Controller General of India. ...atment of chronic hepatitis B virus infection in a... active disease. BARACLUDE? is an oral antiv...
...management training center, not only training Indi...tries//. The MV Hospital for Diabetes and Diabetes...zation’s collaborating centre for diabetes researc...e center is currently coaching a Pakistani physici...
Other Medicine News:Health News:Ecological Changes affects human health, food security 2Health News:Bone Marrow Cells Aid In Heart Repair 2Health News:Bone Marrow Cells Aid In Heart Repair 3Health News:India Approves Baraclude? (entecavir) For ,Treatment Of Chronic HEPATITIS B 2
(Date:11/30/2009).../ -- Reportlinker.com announces that a new market ..., Inflammatory Disorders: Therapies That Suppres...w.reportlinker.com/p0165600/Inflammatory-Disorders...ponse.html ,, The human immune system can go a...ing an exaggerated response to a foreign substance...
(Date:11/30/2009)... Jocelyn Rapelyea, Associate Director of Breast Im...sity Medical Center in Washington, D.C., demonstra...ific Gamma Imaging (BSGI) can be localized utilizi...l, as for pre-operative localization today at the ...h America (RSNA). ,, BSGI was conducted using a...
(Date:11/30/2009)...- Minimally-invasive procedures are increasingly r... oncology, cardiology and women,s health applicati...tion expected to reach $600 million by 2015, clini...mally-invasive procedures, including shorter patie...ter patient throughput. ,, (Logo: http://www...
Breaking Medicine Technology:Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 2Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 3Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 4Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 5Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 3Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 4Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 5Lexington Health Care Names New Chief Executive Officer 51899 1Lexington Health Care Names New Chief Executive Officer 51899 2Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 51897 1Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 51897 2Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 51897 3Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 51897 4PAL Health Technologies Wins State Level Prestigious Employer of the Year Award 51895 1PAL Health Technologies Wins State Level Prestigious Employer of the Year Award 51895 2
...ults of Roche and Ipsen,s First Once-Weekly Human ...iation Meeting -, NUTLEY, N.J., June 10 Roche an...poglutide (R1583) has been shown to provide,signif...oss after only,eight weeks of treatment(1,2) with ...try into Phase III. Taspoglutide, originating from...
...estigational Diabetes Therapy Also Improved Glucos... Taken Twice a Day, SAN FRANCISCO, June 9 Amylin...and Company (NYSE: LLY ), and Alkermes, Inc.,(Nas...k open-label clinical,study that showed the durabl... release formulation of exenatide. Patients taking...
Other Medicine Technology:Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 2Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 3Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 4Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 5Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 6After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 2After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 3After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 4After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 5After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 6After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 7After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 8After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 9
Cushing Burr
Doro J-Arm Retractor System
Molt 9
Langenbeck Periosteal Elevators
Medicine Products: